Are there sex differences in potentially inappropriate prescribing in adults with multimorbidity?


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
08 2021
Historique:
revised: 02 04 2021
received: 03 12 2020
accepted: 08 04 2021
pubmed: 8 5 2021
medline: 3 8 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

Limited knowledge exists regarding sex differences in prescribing potentially inappropriate medications (PIMs) for various multimorbidity patterns. This study sought to determine sex differences in PIM prescribing in older adults with cardiovascular-metabolic patterns. Retrospective cohort study. Health and Retirement Study (HRS) 2004-2014 interview data, linked to HRS-Medicare claims data annualized for 2005-2014. Six thousand three-hundred and forty-one HRS participants aged 65 and older with two and more chronic conditions. PIM events were calculated using 2015 American Geriatrics Society Beers Criteria. Multimorbidity patterns included: "cardiovascular-metabolic only," "cardiovascular-metabolic plus other physical conditions," "cardiovascular-metabolic plus mental conditions," and "no cardiovascular-metabolic disease" patterns. Logistic regression models were used to determine the association between PIM and sex, including interaction between sex and multimorbidity categories in the model, for PIM overall and for each PIM drug class. Women were prescribed PIMs more often than men (39.4% vs 32.8%). Overall, women had increased odds of PIM (Adj. odds ratio [OR] = 1.30, 95% confidence interval [CI]: 1.16-1.46). Women had higher odds of PIM than men with cardiovascular-metabolic plus physical patterns (Adj. OR = 1.25, 95% CI: 1.07-1.45) and cardiovascular-metabolic plus mental patterns (Adj. OR = 1.25, 95% CI: 1.06-1.48), and there were no sex differences in adults with a cardiovascular-metabolic only patterns (Adj. OR = 1.13, 95% CI: 0.79-1.62). Women had greater odds of being prescribed the following PIMs: anticholinergics, antidepressants, antispasmodics, benzodiazepines, skeletal muscle relaxants, and had lower odds of being prescribed pain drugs and sulfonylureas compared with men. This study evaluated sex differences in PIM prescribing among adults with complex cardiovascular-metabolic multimorbidity patterns. The effect of sex varied across multimorbidity patterns and by different PIM drug classes. This study identified important opportunities for future interventions to improve medication prescribing among older adults at risk for PIM.

Sections du résumé

BACKGROUND/OBJECTIVES
Limited knowledge exists regarding sex differences in prescribing potentially inappropriate medications (PIMs) for various multimorbidity patterns. This study sought to determine sex differences in PIM prescribing in older adults with cardiovascular-metabolic patterns.
DESIGN
Retrospective cohort study.
SETTING
Health and Retirement Study (HRS) 2004-2014 interview data, linked to HRS-Medicare claims data annualized for 2005-2014.
STUDY SAMPLE
Six thousand three-hundred and forty-one HRS participants aged 65 and older with two and more chronic conditions.
MEASUREMENTS
PIM events were calculated using 2015 American Geriatrics Society Beers Criteria. Multimorbidity patterns included: "cardiovascular-metabolic only," "cardiovascular-metabolic plus other physical conditions," "cardiovascular-metabolic plus mental conditions," and "no cardiovascular-metabolic disease" patterns. Logistic regression models were used to determine the association between PIM and sex, including interaction between sex and multimorbidity categories in the model, for PIM overall and for each PIM drug class.
RESULTS
Women were prescribed PIMs more often than men (39.4% vs 32.8%). Overall, women had increased odds of PIM (Adj. odds ratio [OR] = 1.30, 95% confidence interval [CI]: 1.16-1.46). Women had higher odds of PIM than men with cardiovascular-metabolic plus physical patterns (Adj. OR = 1.25, 95% CI: 1.07-1.45) and cardiovascular-metabolic plus mental patterns (Adj. OR = 1.25, 95% CI: 1.06-1.48), and there were no sex differences in adults with a cardiovascular-metabolic only patterns (Adj. OR = 1.13, 95% CI: 0.79-1.62). Women had greater odds of being prescribed the following PIMs: anticholinergics, antidepressants, antispasmodics, benzodiazepines, skeletal muscle relaxants, and had lower odds of being prescribed pain drugs and sulfonylureas compared with men.
CONCLUSION
This study evaluated sex differences in PIM prescribing among adults with complex cardiovascular-metabolic multimorbidity patterns. The effect of sex varied across multimorbidity patterns and by different PIM drug classes. This study identified important opportunities for future interventions to improve medication prescribing among older adults at risk for PIM.

Identifiants

pubmed: 33959939
doi: 10.1111/jgs.17194
pmc: PMC8373665
mid: NIHMS1704548
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2163-2175

Subventions

Organisme : NIA NIH HHS
ID : R01 AG055681
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG055681
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG055681-02S2
Pays : United States

Informations de copyright

© 2021 The American Geriatrics Society.

Références

Int J Environ Res Public Health. 2016 Mar 31;13(4):391
pubmed: 27043599
Eur J Clin Pharmacol. 2012 Oct;68(10):1425-33
pubmed: 22447297
Int J Environ Res Public Health. 2019 Apr 01;16(7):
pubmed: 30939754
Circulation. 2011 Nov 8;124(19):2145-54
pubmed: 22064958
J Gen Intern Med. 2007 Dec;22(12):1635-40
pubmed: 17647065
J Am Heart Assoc. 2020 Jun 2;9(11):e014742
pubmed: 32431190
Ann Clin Psychiatry. 2019 May;31(2):144-152
pubmed: 31046036
Eur J Clin Pharmacol. 2015 Sep;71(9):1037-50
pubmed: 26111636
Ann Pharmacother. 2009 Jul;43(7):1233-8
pubmed: 19584395
Eur J Intern Med. 2015 Sep;26(7):483-90
pubmed: 26209883
Age Ageing. 2016 Jul;45(4):535-42
pubmed: 27151390
J Gen Intern Med. 2019 May;34(Suppl 1):43-49
pubmed: 31098975
J Gen Intern Med. 2001 Apr;16(4):211-7
pubmed: 11318921
Health Serv Res. 2017 Aug;52(4):1534-1549
pubmed: 27686781
J Am Geriatr Soc. 2015 Mar;63(3):486-500
pubmed: 25752646
J Diabetes Complications. 2015 Mar;29(2):288-94
pubmed: 25456821
Br J Clin Pharmacol. 2012 Dec;74(6):1045-52
pubmed: 22533339
Br J Gen Pract. 2011 Jan;61(582):e12-21
pubmed: 21401985
J Am Geriatr Soc. 2015 Nov;63(11):2227-46
pubmed: 26446832
BMJ. 2018 Nov 14;363:k4524
pubmed: 30429122
J Am Geriatr Soc. 2016 Apr;64(4):788-97
pubmed: 27100575
J Am Coll Cardiol. 2019 May 28;73(20):2584-2595
pubmed: 31118153
J Comorb. 2016 Apr 21;6(2):46-49
pubmed: 29090172
J Am Board Fam Med. 2009 Mar-Apr;22(2):187-95
pubmed: 19264942
Diabetes Metab Syndr Obes. 2019 Mar 18;12:333-356
pubmed: 31114271
BMC Cardiovasc Disord. 2017 Jul 17;17(1):189
pubmed: 28716041
Clinics (Sao Paulo). 2011;66(11):1867-72
pubmed: 22086515
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
Epidemiol Rev. 2013;35:75-83
pubmed: 23372025
Prev Chronic Dis. 2013 Apr 25;10:E66
pubmed: 23618546
J Am Geriatr Soc. 2020 Nov;68(11):2542-2550
pubmed: 32757494
Public Health Rep. 2011 Jul-Aug;126(4):460-71
pubmed: 21800741
Am J Geriatr Pharmacother. 2007 Jun;5(2):147-61
pubmed: 17719517
Int J Epidemiol. 2014 Apr;43(2):576-85
pubmed: 24671021
PLoS One. 2016 Apr 19;11(4):e0151066
pubmed: 27093289
Drugs Aging. 2009 Dec;26 Suppl 1:31-9
pubmed: 20136167
Arch Intern Med. 2002 Nov 11;162(20):2269-76
pubmed: 12418941
Am J Manag Care. 2011 Feb;17(2):118-22
pubmed: 21473661
Handb Exp Pharmacol. 2012;(214):211-36
pubmed: 23027453
BMJ Open. 2013 May 03;3(5):
pubmed: 23645921
Int J Cardiol. 2017 Apr 1;232:216-221
pubmed: 28111054
PLoS One. 2019 Dec 30;14(12):e0226511
pubmed: 31887163
PLoS One. 2014 Jul 21;9(7):e102149
pubmed: 25048354
BJPsych Bull. 2017 Jun;41(3):145-150
pubmed: 28584650

Auteurs

Maria Ukhanova (M)

Department of Family Medicine, Oregon Health and Science University, Portland, Oregon, USA.

Sheila Markwardt (S)

School of Public Health, Oregon Health & Science University, Portland, Oregon, USA.

Jon P Furuno (JP)

Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA.

Laura Davis (L)

Neighborhood Health Center, Hillsboro, Oregon, USA.

Brie N Noble (BN)

Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA.

Ana R Quiñones (AR)

Department of Family Medicine, Oregon Health and Science University, Portland, Oregon, USA.
School of Public Health, Oregon Health & Science University, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH